HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Im Il Na Selected Research
Im Il Na Research Topics
Disease
11
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2012 - 06/2007
8
Neoplasms (Cancer)
01/2023 - 08/2006
5
Lung Neoplasms (Lung Cancer)
01/2019 - 08/2006
3
Neoplasm Metastasis (Metastasis)
01/2016 - 09/2008
3
Adenocarcinoma
01/2016 - 02/2014
2
Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
02/2016 - 10/2008
2
Thyroid Neoplasms (Thyroid Cancer)
03/2014 - 12/2008
2
Stomach Neoplasms (Stomach Cancer)
09/2008 - 09/2007
1
Sarcoma (Soft Tissue Sarcoma)
05/2024
1
Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
12/2023
1
Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
12/2023
1
Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2023
1
Lymphoma (Lymphomas)
01/2023
1
Breast Neoplasms (Breast Cancer)
12/2021
1
Adenocarcinoma of Lung
01/2019
1
Biliary Tract Neoplasms (Biliary Tract Cancer)
07/2017
1
Small Cell Lung Carcinoma (Small Cell Lung Cancer)
03/2014
1
Cushing Syndrome
03/2014
1
Carcinoid Tumor (Carcinoid)
03/2014
1
Brain Neoplasms (Brain Tumor)
02/2014
1
Small Cell Carcinoma
04/2010
1
Leukemia
12/2008
1
Hematologic Neoplasms (Hematological Malignancy)
12/2008
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
12/2008
1
Tonsillar Neoplasms
02/2007
1
Infections
02/2007
1
Squamous Cell Carcinoma of Head and Neck
02/2007
1
Familial primary gastric lymphoma
10/2006
1
Squamous Cell Carcinoma (Epidermoid Carcinoma)
08/2006
1
Multiple Myeloma
08/2005
Drug/Important Bio-Agent (IBA)
14
ErbB Receptors (EGF Receptor)
IBA
12/2021 - 08/2006
6
Gefitinib (Iressa)
FDA Link
04/2012 - 08/2006
4
Cisplatin (Platino)
FDA Link
Generic
07/2017 - 09/2007
3
Tyrosine Kinase Inhibitors
IBA
01/2019 - 10/2009
2
Rituximab (Mabthera)
FDA Link
12/2023 - 02/2016
2
Fluorouracil (Carac)
FDA Link
Generic
01/2016 - 09/2007
2
Erlotinib Hydrochloride (CP 358,774)
FDA Link
04/2012 - 01/2011
2
Platinum
IBA
01/2011 - 09/2007
2
Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)
FDA Link
01/2010 - 10/2008
2
Protein-Tyrosine Kinases (Tyrosine Kinase)
IBA
02/2007 - 08/2006
1
131I-rituximab
IBA
01/2023
1
Biomarkers (Surrogate Marker)
IBA
01/2019
1
Carcinoembryonic Antigen
IBA
07/2017
1
Carbohydrates
IBA
07/2017
1
Antigens
IBA
07/2017
1
Tumor Biomarkers (Tumor Markers)
IBA
07/2017
1
Cyclophosphamide (Cytoxan)
FDA Link
Generic
02/2016
1
Vincristine (Oncovin)
FDA Link
Generic
02/2016
1
Prednisolone (Predate)
FDA Link
Generic
02/2016
1
Doxorubicin (Adriamycin)
FDA Link
Generic
02/2016
1
Oxaliplatin (Eloxatin)
FDA Link
Generic
01/2016
1
Leucovorin (Folinic Acid)
FDA Link
01/2016
1
hydroxide ion
IBA
10/2014
1
25-hydroxyvitamin D
IBA
10/2014
1
Adrenocorticotropic Hormone (ACTH)
FDA Link
03/2014
1
Phosphotransferases (Kinase)
IBA
04/2012
1
phosphatidyl-N-monomethylaminoethanol
IBA
01/2011
1
Trypan Blue
FDA Link
01/2011
1
Paraffin
IBA
12/2010
1
Pemetrexed (MTA)
FDA Link
04/2010
1
Iodine
IBA
12/2008
1
Paclitaxel (Taxol)
FDA Link
Generic
09/2007
1
DNA (Deoxyribonucleic Acid)
IBA
02/2007
1
Bortezomib (Velcade)
FDA Link
08/2005
1
Proteasome Inhibitors
IBA
08/2005
Therapy/Procedure
7
Drug Therapy (Chemotherapy)
05/2024 - 08/2006
5
Therapeutics
01/2023 - 09/2007
2
Radioimmunotherapy
12/2023 - 01/2023
1
Adrenalectomy
03/2014
1
Thyroidectomy
12/2008
1
Folfox protocol
09/2008
1
TP protocol
09/2007
1
Aftercare (After-Treatment)
10/2006